This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
Delivered as Hybrid Event from 15-18 November 2022
Live In-Person Conference Delivered 15-18 NovemberAustria Center Vienna

Marianna Yanez Arteta, Ph.D.
Associate Director at AstraZeneca


Marianna Yanez Arteta, Ph.D., is an Associate Principal Scientist at the Advanced Drug Delivery division within Pharmaceutical Sciences in AstraZeneca. In her current position she leads the development of new modalities drug products in pre-clinical and early clinical phases, including mRNA, antisense oligonucleotides and peptides. As part of her role, she has guided the development of nanomedicines for complex therapeutics from the understanding of the molecular interactions in the formulation.

Agenda Sessions

  • Apolipoprotein E Binding Drives Structural and Compositional Changes of mRNA Containing Lipid Nanoparticles